Financials
Value Q3, 25Q4, 25 TTM Selling/general/admin expenses 3.9 M— — Research & development 2.49 M— — Operating income 27.25 M— — Non-Operating Income, Total —— — Interest expense, net of interest capitalized 0— — Non-Operating Income, excl. Interest Expenses —— — Unusual income/expense —— — Pretax income 28.35 M— — Equity in earnings —— — Taxes 7.2 M27.84 M — Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations 21.15 M-27.84 M — Discontinued operations 0— — Net income 21.15 M-27.84 M — Dilution adjustment -1.03 M— — Preferred dividends 0— — Diluted net income available to common stockholders 20.12 M-27.84 M — Basic earnings per share (Basic EPS) 0.25— — Diluted earnings per share (Diluted EPS) 0.25-0.35 — Average basic shares outstanding 78.74 M80.17 M — Diluted shares outstanding 78.74 M80.17 M — EBITDA 27.87 M— — EBIT 27.25 M— — Cost of revenue 21.39 M— — Other cost of goods sold 5.09 M— — Depreciation & amortization (cash flow) 622 K— —